Ranish K. Patel

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Brett C. Sheppard · 6 shared papers, 2023–2025 · strength 1.15
   • Paper Early detection of pancreatic cancer by a high-throughput protease-activated nanosensor assay. DOI 10.1126/scitranslmed.adq3110↗
   • Paper Rapid metastatic recurrence after pancreatic cancer resection: a multi-center, regional analysis of trends in surgical … DOI 10.1016/j.hpb.2024.08.006↗
   • Paper High-volume centers are associated with higher receipt of combined therapy in stage III pancreatic cancer. DOI 10.1016/j.amjsurg.2023.02.012↗
2. Charles D. Lopez · 4 shared papers, 2023–2025 · strength 0.74
   • Paper Early detection of pancreatic cancer by a high-throughput protease-activated nanosensor assay. DOI 10.1126/scitranslmed.adq3110↗
   • Paper A high throughput blood-based assay for the early detection of pancreatic cancer DOI 10.1101/2024.01.12.24301220↗
   • Paper Neoadjuvant therapy does not impact the biliary microbiome in patients with pancreatic cancer. DOI 10.1002/jso.27281↗
3. Flavio G. Rocha · 2 shared papers, 2024 · strength 0.66
   • Paper Reply to: Letter to Editor Entitled "Endoscopy's Evolving Role in Locally Advanced and Borderline Resectable Pancreatic… DOI 10.1245/s10434-024-15859-9↗
   • Paper Rapid metastatic recurrence after pancreatic cancer resection: a multi-center, regional analysis of trends in surgical … DOI 10.1016/j.hpb.2024.08.006↗
4. Thomas Lee Sutton · 3 shared papers, 2023–2024 · strength 0.57
   • Paper Rapid metastatic recurrence after pancreatic cancer resection: a multi-center, regional analysis of trends in surgical … DOI 10.1016/j.hpb.2024.08.006↗
   • Paper High-volume centers are associated with higher receipt of combined therapy in stage III pancreatic cancer. DOI 10.1016/j.amjsurg.2023.02.012↗
   • Paper Neoadjuvant therapy does not impact the biliary microbiome in patients with pancreatic cancer. DOI 10.1002/jso.27281↗
5. Melissa H. Wong · 3 shared papers, 2024–2025 · strength 0.57
   • Paper Early detection of pancreatic cancer by a high-throughput protease-activated nanosensor assay. DOI 10.1126/scitranslmed.adq3110↗
   • Paper A high throughput blood-based assay for the early detection of pancreatic cancer DOI 10.1101/2024.01.12.24301220↗
   • Paper Circulating Neoplastic-Immune Hybrid Cells Are Biomarkers of Occult Metastasis and Treatment Response in Pancreatic Can… DOI 10.3390/cancers16213650↗
6. Jose L. Montoya Mira · 2 shared papers, 2024–2025 · strength 0.40
   • Paper Early detection of pancreatic cancer by a high-throughput protease-activated nanosensor assay. DOI 10.1126/scitranslmed.adq3110↗
   • Paper A high throughput blood-based assay for the early detection of pancreatic cancer DOI 10.1101/2024.01.12.24301220↗
7. Rosalie C. Sears · 2 shared papers, 2024–2025 · strength 0.40
   • Paper Early detection of pancreatic cancer by a high-throughput protease-activated nanosensor assay. DOI 10.1126/scitranslmed.adq3110↗
   • Paper A high throughput blood-based assay for the early detection of pancreatic cancer DOI 10.1101/2024.01.12.24301220↗
8. Jared Michael Fischer · 2 shared papers, 2024–2025 · strength 0.40
   • Paper Early detection of pancreatic cancer by a high-throughput protease-activated nanosensor assay. DOI 10.1126/scitranslmed.adq3110↗
   • Paper A high throughput blood-based assay for the early detection of pancreatic cancer DOI 10.1101/2024.01.12.24301220↗
9. Shay Behrens · 2 shared papers, 2023 · strength 0.36
   • Paper High-volume centers are associated with higher receipt of combined therapy in stage III pancreatic cancer. DOI 10.1016/j.amjsurg.2023.02.012↗
   • Paper Neoadjuvant therapy does not impact the biliary microbiome in patients with pancreatic cancer. DOI 10.1002/jso.27281↗
10. Skye C. Mayo · 2 shared papers, 2023–2024 · strength 0.34
    • Paper Neoadjuvant therapy does not impact the biliary microbiome in patients with pancreatic cancer. DOI 10.1002/jso.27281↗
    • Paper Circulating Neoplastic-Immune Hybrid Cells Are Biomarkers of Occult Metastasis and Treatment Response in Pancreatic Can… DOI 10.3390/cancers16213650↗
11. Pavlos Papavasiliou · 1 shared paper, 2024 · strength 0.21
    • Paper Rapid metastatic recurrence after pancreatic cancer resection: a multi-center, regional analysis of trends in surgical … DOI 10.1016/j.hpb.2024.08.006↗
12. Patrick Joseph Worth · 1 shared paper, 2024 · strength 0.21
    • Paper Rapid metastatic recurrence after pancreatic cancer resection: a multi-center, regional analysis of trends in surgical … DOI 10.1016/j.hpb.2024.08.006↗
13. Aaron J. Grossberg · 1 shared paper, 2023 · strength 0.17
    • Paper Neoadjuvant therapy does not impact the biliary microbiome in patients with pancreatic cancer. DOI 10.1002/jso.27281↗
14. Gordon Brent Mills · 1 shared paper, 2024 · strength 0.17
    • Paper Circulating Neoplastic-Immune Hybrid Cells Are Biomarkers of Occult Metastasis and Treatment Response in Pancreatic Can… DOI 10.3390/cancers16213650↗
15. Summer L. Gibbs · 1 shared paper, 2024 · strength 0.17
    • Paper Circulating Neoplastic-Immune Hybrid Cells Are Biomarkers of Occult Metastasis and Treatment Response in Pancreatic Can… DOI 10.3390/cancers16213650↗
16. Lei G. Wang · 1 shared paper, 2024 · strength 0.17
    • Paper Circulating Neoplastic-Immune Hybrid Cells Are Biomarkers of Occult Metastasis and Treatment Response in Pancreatic Can… DOI 10.3390/cancers16213650↗
17. Adel Kardosh · 1 shared paper, 2024 · strength 0.17
    • Paper Circulating Neoplastic-Immune Hybrid Cells Are Biomarkers of Occult Metastasis and Treatment Response in Pancreatic Can… DOI 10.3390/cancers16213650↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.